HEMA:PA:PA-HSBC MSCI Emerging Markets UCITS ETF USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 11.4

Change

+0.13 (+1.15)%

Market Cap

N/A

Volume

1.38K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

N/A

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.50 (+0.60%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.55 (+0.37%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.23 (+0.63%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.48 (+0.58%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+5.00 (+0.98%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.01 (+0.55%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.28 (+0.48%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.12 (+0.59%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.91 (+0.55%)

USD 5.17B

ETFs Containing HEMA:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.59% 62% D 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.59% 62% D 60% D-
Trailing 12 Months  
Capital Gain 16.21% 60% D- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.21% 58% F 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.94% 41% F 52% F
Dividend Return 5.94% 38% F 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.58% 77% C+ 93% A
Risk Adjusted Return 78.38% 59% D- 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.